speb/financial-data huggingface dataset:
BIOA balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 0.00
BIOA balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 0.00
BIOA balance_sheet (annual, 2022-12-31) — Current Liabilities: 5861000.00
BIOA cash_flow (annual, 2022-12-31) — Depreciation: 129000.00
BIOA cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 129000.00
BIOA cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 129000.00
BIOA balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 153000.00
BIOA income_statement (annual, 2022-12-31) — Diluted Average Shares: 1671761.00
BIOA income_statement (annual, 2022-12-31) — Diluted EPS: -23.76
BIOA income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -39722000.00
BIOA income_statement (annual, 2022-12-31) — EBIT: -39481000.00
BIOA income_statement (annual, 2022-12-31) — EBITDA: -39352000.00
BIOA cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 246000.00
BIOA cash_flow (annual, 2022-12-31) — End Cash Position: 27644000.00
BIOA cash_flow (annual, 2022-12-31) — Financing Cash Flow: 2499000.00
BIOA cash_flow (annual, 2022-12-31) — Free Cash Flow: -36284000.00
BIOA cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -23000.00
BIOA income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 23000.00
BIOA balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 167000.00
BIOA income_statement (annual, 2022-12-31) — General And Administrative Expense: 9447000.00
BIOA balance_sheet (annual, 2022-12-31) — Gross PPE: 627000.00
BIOA income_statement (annual, 2022-12-31) — Interest Expense: 241000.00
BIOA income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 241000.00
BIOA income_statement (annual, 2022-12-31) — Interest Income: 465000.00
BIOA income_statement (annual, 2022-12-31) — Interest Income Non Operating: 465000.00
BIOA cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 129000.00
BIOA balance_sheet (annual, 2022-12-31) — Invested Capital: -110140000.00
BIOA cash_flow (annual, 2022-12-31) — Investing Cash Flow: -103000.00
BIOA balance_sheet (annual, 2022-12-31) — Investments And Advances: 0.00
BIOA cash_flow (annual, 2022-12-31) — Issuance Of Debt: 2500000.00
BIOA balance_sheet (annual, 2022-12-31) — Long Term Debt: 2252000.00
BIOA balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 2252000.00
BIOA cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 2500000.00
BIOA cash_flow (annual, 2022-12-31) — Long Term Debt Payments: 0.00
BIOA balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 305000.00
BIOA income_statement (annual, 2022-12-31) — Net Income: -39722000.00
BIOA income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -39722000.00
BIOA income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -39722000.00
BIOA income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -39722000.00
BIOA income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -39722000.00
BIOA cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -39722000.00
BIOA income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -39722000.00
BIOA income_statement (annual, 2022-12-31) — Net Interest Income: 224000.00
BIOA cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 0.00
BIOA cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 2500000.00
BIOA cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 2500000.00
BIOA income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 224000.00
BIOA cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -45000.00
BIOA balance_sheet (annual, 2022-12-31) — Net PPE: 374000.00
BIOA cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -103000.00
BIOA cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 0.00
BIOA balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -112559000.00
BIOA income_statement (annual, 2022-12-31) — Normalized EBITDA: -39375000.00
BIOA income_statement (annual, 2022-12-31) — Normalized Income: -39745000.00
BIOA cash_flow (annual, 2022-12-31) — Operating Cash Flow: -36181000.00
BIOA cash_flow (annual, 2022-12-31) — Operating Gains Losses: -23000.00
BIOA income_statement (annual, 2022-12-31) — Operating Income: -39969000.00
BIOA income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
BIOA balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 34167184.00
BIOA balance_sheet (annual, 2022-12-31) — Other Current Assets: 386000.00
BIOA balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 167000.00
BIOA balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 24000.00
BIOA balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 167000.00
BIOA income_statement (annual, 2022-12-31) — Other Gand A: 9447000.00
BIOA income_statement (annual, 2022-12-31) — Other Income Expense: 23000.00
BIOA balance_sheet (annual, 2022-12-31) — Other Investments: 0.00
BIOA cash_flow (annual, 2022-12-31) — Other Non Cash Items: 100000.00
BIOA balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 25000.00
BIOA balance_sheet (annual, 2022-12-31) — Other Properties: 322000.00
BIOA balance_sheet (annual, 2022-12-31) — Payables: 2261000.00
BIOA balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 5621000.00
BIOA balance_sheet (annual, 2022-12-31) — Preferred Securities Outside Stock Equity: 132722000.00
BIOA income_statement (annual, 2022-12-31) — Pretax Income: -39722000.00
BIOA cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 44000.00
BIOA cash_flow (annual, 2022-12-31) — Purchase Of Investment: 0.00
BIOA cash_flow (annual, 2022-12-31) — Purchase Of PPE: -103000.00
BIOA income_statement (annual, 2022-12-31) — Reconciled Depreciation: 129000.00
BIOA cash_flow (annual, 2022-12-31) — Repayment Of Debt: 0.00
BIOA income_statement (annual, 2022-12-31) — Research And Development: 30522000.00
BIOA balance_sheet (annual, 2022-12-31) — Restricted Cash: 0.00
BIOA balance_sheet (annual, 2022-12-31) — Retained Earnings: -117848000.00
BIOA income_statement (annual, 2022-12-31) — Selling General And Administration: 9447000.00
BIOA balance_sheet (annual, 2022-12-31) — Share Issued: 34167184.00
BIOA cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 0.00
BIOA cash_flow (annual, 2022-12-31) — Stock Based Compensation: 2540000.00
BIOA balance_sheet (annual, 2022-12-31) — Stockholders Equity: -112559000.00
BIOA balance_sheet (annual, 2022-12-31) — Tangible Book Value: -112559000.00
BIOA income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
BIOA income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
BIOA balance_sheet (annual, 2022-12-31) — Total Assets: 28429000.00
BIOA balance_sheet (annual, 2022-12-31) — Total Capitalization: -110307000.00
BIOA balance_sheet (annual, 2022-12-31) — Total Debt: 2468000.00
BIOA balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: -112559000.00
BIOA income_statement (annual, 2022-12-31) — Total Expenses: 39969000.00
BIOA balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 140988000.00
BIOA balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 399000.00
BIOA balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 135127000.00
BIOA income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -39969000.00
BIOA income_statement (annual, 2022-12-31) — Total Unusual Items: 23000.00
BIOA income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 23000.00
BIOA balance_sheet (annual, 2022-12-31) — Working Capital: 22169000.00
BIOA income_statement (annual, 2023-12-31) — +Operating Expense: 48400000.00
BIOA income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
BIOA balance_sheet (annual, 2023-12-31) — Accounts Payable: 1866000.00
BIOA balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -419000.00
BIOA balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 8142000.00
BIOA income_statement (annual, 2023-12-31) — Basic Average Shares: 20119816.00
BIOA income_statement (annual, 2023-12-31) — Basic EPS: -3.17
BIOA cash_flow (annual, 2023-12-31) — Beginning Cash Position: 27644000.00
BIOA cash_flow (annual, 2023-12-31) — Capital Expenditure: -166000.00
BIOA balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 194000.00
BIOA balance_sheet (annual, 2023-12-31) — Capital Stock: 0.00
BIOA balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 21644000.00
BIOA balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 21644000.00
BIOA cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 34941000.00
BIOA cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -266000.00
BIOA cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -37362000.00
BIOA cash_flow (annual, 2023-12-31) — Change In Account Payable: -393000.00
BIOA cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 3728000.00
BIOA cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 25000.00
BIOA cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 3313000.00
BIOA cash_flow (annual, 2023-12-31) — Change In Payable: -393000.00
BIOA cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 3335000.00
BIOA cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 37000.00
BIOA cash_flow (annual, 2023-12-31) — Change In Working Capital: 6710000.00
BIOA cash_flow (annual, 2023-12-31) — Changes In Cash: -2687000.00
BIOA balance_sheet (annual, 2023-12-31) — Common Stock: 0.00
BIOA balance_sheet (annual, 2023-12-31) — Common Stock Equity: -173396000.00
BIOA cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
BIOA balance_sheet (annual, 2023-12-31) — Construction In Progress: 0.00
BIOA balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 6549000.00
BIOA balance_sheet (annual, 2023-12-31) — Current Assets: 25306000.00
BIOA balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 194000.00
BIOA balance_sheet (annual, 2023-12-31) — Current Debt: 44857000.00
BIOA balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 45051000.00
BIOA balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 3313000.00
BIOA balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 3313000.00
BIOA balance_sheet (annual, 2023-12-31) — Current Liabilities: 58168000.00
BIOA cash_flow (annual, 2023-12-31) — Depreciation: 162000.00
BIOA cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 162000.00
BIOA cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 162000.00
BIOA balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 229000.00
BIOA income_statement (annual, 2023-12-31) — Diluted Average Shares: 20119816.00
BIOA income_statement (annual, 2023-12-31) — Diluted EPS: -3.17
BIOA income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -63854000.00
BIOA income_statement (annual, 2023-12-31) — EBIT: -56060000.00
BIOA income_statement (annual, 2023-12-31) — EBITDA: -55898000.00
BIOA cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 0.00
BIOA cash_flow (annual, 2023-12-31) — End Cash Position: 24957000.00
BIOA cash_flow (annual, 2023-12-31) — Financing Cash Flow: 34941000.00
BIOA cash_flow (annual, 2023-12-31) — Free Cash Flow: -37528000.00
BIOA cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 10091000.00
BIOA cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 0.00
BIOA income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -10091000.00
BIOA balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 164000.00
BIOA income_statement (annual, 2023-12-31) — General And Administrative Expense: 14514000.00
BIOA balance_sheet (annual, 2023-12-31) — Gross PPE: 937000.00
BIOA income_statement (annual, 2023-12-31) — Interest Expense: 7794000.00
BIOA income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 7794000.00
BIOA income_statement (annual, 2023-12-31) — Interest Income: 2431000.00
BIOA income_statement (annual, 2023-12-31) — Interest Income Non Operating: 2431000.00
BIOA cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 1155000.00
BIOA balance_sheet (annual, 2023-12-31) — Invested Capital: -120338000.00
BIOA cash_flow (annual, 2023-12-31) — Investing Cash Flow: -266000.00
BIOA balance_sheet (annual, 2023-12-31) — Investments And Advances: 100000.00
BIOA cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
BIOA cash_flow (annual, 2023-12-31) — Issuance Of Debt: 36000000.00
BIOA balance_sheet (annual, 2023-12-31) — Long Term Debt: 8201000.00
BIOA balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 8201000.00
BIOA cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 12500000.00
BIOA cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -1000000.00
BIOA balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 376000.00
BIOA cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
BIOA balance_sheet (annual, 2023-12-31) — Net Debt: 31414000.00
BIOA income_statement (annual, 2023-12-31) — Net Income: -63854000.00
BIOA income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -63854000.00
BIOA income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -63854000.00
BIOA income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -63854000.00
BIOA income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -63854000.00
BIOA cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -63854000.00
BIOA income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -63854000.00
BIOA income_statement (annual, 2023-12-31) — Net Interest Income: -5363000.00
BIOA cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -100000.00
BIOA cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 35000000.00
BIOA cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 11500000.00
BIOA income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -5363000.00
BIOA cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -63000.00
BIOA balance_sheet (annual, 2023-12-31) — Net PPE: 518000.00
BIOA cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -166000.00
BIOA cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: 0.00
BIOA cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 23500000.00
BIOA balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -173396000.00
BIOA balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 0.00
BIOA balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 0.00
BIOA income_statement (annual, 2023-12-31) — Normalized EBITDA: -45807000.00
BIOA income_statement (annual, 2023-12-31) — Normalized Income: -53763000.00
BIOA cash_flow (annual, 2023-12-31) — Operating Cash Flow: -37362000.00
BIOA cash_flow (annual, 2023-12-31) — Operating Gains Losses: 10091000.00
BIOA income_statement (annual, 2023-12-31) — Operating Income: -48400000.00
BIOA income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
BIOA balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 34167184.00
BIOA balance_sheet (annual, 2023-12-31) — Other Current Assets: 349000.00
BIOA balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 44857000.00
BIOA balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 1389000.00
BIOA balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 164000.00
BIOA income_statement (annual, 2023-12-31) — Other Gand A: 14514000.00
BIOA income_statement (annual, 2023-12-31) — Other Income Expense: -10091000.00
BIOA balance_sheet (annual, 2023-12-31) — Other Investments: 100000.00
BIOA cash_flow (annual, 2023-12-31) — Other Non Cash Items: 6513000.00
BIOA balance_sheet (annual, 2023-12-31) — Other Properties: 561000.00
BIOA balance_sheet (annual, 2023-12-31) — Payables: 1866000.00
BIOA balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 8415000.00
BIOA balance_sheet (annual, 2023-12-31) — Preferred Securities Outside Stock Equity: 132722000.00
BIOA cash_flow (annual, 2023-12-31) — Preferred Stock Issuance: 0.00
BIOA income_statement (annual, 2023-12-31) — Pretax Income: -63854000.00
BIOA cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 4000.00
BIOA cash_flow (annual, 2023-12-31) — Purchase Of Investment: -100000.00
BIOA cash_flow (annual, 2023-12-31) — Purchase Of PPE: -166000.00
BIOA income_statement (annual, 2023-12-31) — Reconciled Depreciation: 162000.00
BIOA cash_flow (annual, 2023-12-31) — Repayment Of Debt: -1000000.00
BIOA income_statement (annual, 2023-12-31) — Research And Development: 33886000.00
BIOA balance_sheet (annual, 2023-12-31) — Restricted Cash: 3313000.00
BIOA balance_sheet (annual, 2023-12-31) — Retained Earnings: -181702000.00
BIOA income_statement (annual, 2023-12-31) — Selling General And Administration: 14514000.00
BIOA balance_sheet (annual, 2023-12-31) — Share Issued: 34167184.00
BIOA cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 23500000.00
BIOA income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
BIOA cash_flow (annual, 2023-12-31) — Stock Based Compensation: 3016000.00
BIOA balance_sheet (annual, 2023-12-31) — Stockholders Equity: -173396000.00
BIOA balance_sheet (annual, 2023-12-31) — Tangible Book Value: -173396000.00
BIOA income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
BIOA income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
BIOA balance_sheet (annual, 2023-12-31) — Total Assets: 25924000.00
BIOA balance_sheet (annual, 2023-12-31) — Total Capitalization: -165195000.00
BIOA balance_sheet (annual, 2023-12-31) — Total Debt: 53252000.00
BIOA balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -173396000.00
BIOA income_statement (annual, 2023-12-31) — Total Expenses: 48400000.00
BIOA balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 199320000.00
BIOA balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 618000.00
BIOA balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 141152000.00
BIOA income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -48400000.00
BIOA income_statement (annual, 2023-12-31) — Total Unusual Items: -10091000.00
BIOA income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -10091000.00
BIOA balance_sheet (annual, 2023-12-31) — Working Capital: -32862000.00
BIOA income_statement (quarterly, 2024-09-30) — Basic Average Shares: 3494580.00
BIOA income_statement (quarterly, 2024-09-30) — Basic EPS: -6.70
BIOA income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 3494580.00
BIOA income_statement (quarterly, 2024-09-30) — Diluted EPS: -6.70
BIOA cash_flow (quarterly, 2024-09-30) — Issuance Of Debt: 0.00
BIOA balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 3940000.00
BIOA cash_flow (quarterly, 2024-09-30) — Long Term Debt Issuance: 0.00
BIOA cash_flow (quarterly, 2024-09-30) — Net Other Financing Charges: -1999000.00
BIOA cash_flow (quarterly, 2024-09-30) — Net Short Term Debt Issuance: 0.00
BIOA balance_sheet (quarterly, 2024-09-30) — Preferred Securities Outside Stock Equity: 0.00
BIOA balance_sheet (quarterly, 2024-09-30) — Restricted Cash: 0.00
BIOA cash_flow (quarterly, 2024-09-30) — Short Term Debt Issuance: 0.00
BIOA income_statement (annual, 2024-12-31) — +Operating Expense: 78194000.00
BIOA income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
BIOA balance_sheet (annual, 2024-12-31) — Accounts Payable: 1996000.00
BIOA balance_sheet (annual, 2024-12-31) — Accounts Receivable: 0.00
BIOA balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -371000.00
BIOA balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 575693000.00
BIOA income_statement (annual, 2024-12-31) — Basic Average Shares: 10726521.00
BIOA income_statement (annual, 2024-12-31) — Basic EPS: -6.63
BIOA cash_flow (annual, 2024-12-31) — Beginning Cash Position: 24957000.00
BIOA cash_flow (annual, 2024-12-31) — Capital Expenditure: -366000.00
BIOA balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 202000.00
BIOA balance_sheet (annual, 2024-12-31) — Capital Stock: 0.00
BIOA balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 354349000.00
BIOA balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 354349000.00
BIOA cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 381199000.00
BIOA cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -366000.00
BIOA cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -51522000.00
BIOA cash_flow (annual, 2024-12-31) — Change In Account Payable: 6000.00
BIOA cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 4628000.00
BIOA cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -240000.00
BIOA cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 9187000.00
BIOA cash_flow (annual, 2024-12-31) — Change In Payable: 6000.00
BIOA cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 4634000.00
BIOA cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -2405000.00
BIOA cash_flow (annual, 2024-12-31) — Change In Receivables: 0.00
BIOA cash_flow (annual, 2024-12-31) — Change In Working Capital: 11176000.00
BIOA cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 0.00
BIOA cash_flow (annual, 2024-12-31) — Changes In Cash: 329311000.00
BIOA balance_sheet (annual, 2024-12-31) — Common Stock: 0.00
BIOA balance_sheet (annual, 2024-12-31) — Common Stock Equity: 323127000.00
BIOA cash_flow (annual, 2024-12-31) — Common Stock Issuance: 221619000.00
BIOA cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 27621000.00
BIOA balance_sheet (annual, 2024-12-31) — Construction In Progress: 176000.00
BIOA balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 11334000.00
BIOA balance_sheet (annual, 2024-12-31) — Current Assets: 357103000.00
BIOA balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 202000.00
BIOA balance_sheet (annual, 2024-12-31) — Current Debt: 6000000.00
BIOA balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 6202000.00
BIOA balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 7826000.00
BIOA balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 7826000.00
BIOA balance_sheet (annual, 2024-12-31) — Current Liabilities: 27775000.00
BIOA cash_flow (annual, 2024-12-31) — Depreciation: 167000.00
BIOA cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 167000.00
BIOA cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 167000.00
BIOA balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 156000.00
BIOA income_statement (annual, 2024-12-31) — Diluted Average Shares: 10726521.00
BIOA income_statement (annual, 2024-12-31) — Diluted EPS: -6.63
BIOA income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -71109000.00
BIOA income_statement (annual, 2024-12-31) — EBIT: -68742000.00
BIOA income_statement (annual, 2024-12-31) — EBITDA: -68575000.00
BIOA cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 81000.00
BIOA cash_flow (annual, 2024-12-31) — End Cash Position: 354349000.00
BIOA cash_flow (annual, 2024-12-31) — Financing Cash Flow: 381199000.00
BIOA cash_flow (annual, 2024-12-31) — Free Cash Flow: -51888000.00
BIOA cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -73000.00
BIOA cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 55000.00
BIOA income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 73000.00
BIOA balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 245000.00
BIOA income_statement (annual, 2024-12-31) — General And Administrative Expense: 19158000.00
BIOA balance_sheet (annual, 2024-12-31) — Gross PPE: 1162000.00
BIOA income_statement (annual, 2024-12-31) — Interest Expense: 2367000.00
BIOA income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 2367000.00
BIOA income_statement (annual, 2024-12-31) — Interest Income: 9629000.00
BIOA income_statement (annual, 2024-12-31) — Interest Income Non Operating: 9629000.00
BIOA cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 1420000.00
BIOA balance_sheet (annual, 2024-12-31) — Invested Capital: 331629000.00
BIOA cash_flow (annual, 2024-12-31) — Investing Cash Flow: -366000.00
BIOA balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 0.00
BIOA balance_sheet (annual, 2024-12-31) — Investments And Advances: 100000.00
BIOA cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 391619000.00
BIOA cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
BIOA cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
BIOA balance_sheet (annual, 2024-12-31) — Leases: 0.00
BIOA balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 0.00
BIOA balance_sheet (annual, 2024-12-31) — Long Term Debt: 2502000.00
BIOA balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 2502000.00
BIOA balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 2502000.00
BIOA cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
BIOA cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
BIOA cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -6000000.00
BIOA balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 117000.00
BIOA cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 221619000.00
BIOA cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 27621000.00
BIOA income_statement (annual, 2024-12-31) — Net Income: -71109000.00
BIOA income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -71109000.00
BIOA income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -71109000.00
BIOA income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -71109000.00
BIOA income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -71109000.00
BIOA cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -71109000.00
BIOA income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -71109000.00
BIOA income_statement (annual, 2024-12-31) — Net Interest Income: 7262000.00
BIOA cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 0.00
BIOA cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -6000000.00
BIOA cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -6000000.00
BIOA income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 7262000.00
BIOA cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -5054000.00
BIOA cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: -1244000.00
BIOA balance_sheet (annual, 2024-12-31) — Net PPE: 791000.00
BIOA cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -366000.00
BIOA cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 170000000.00
BIOA cash_flow (quarterly, 2024-12-31) — Net Preferred Stock Issuance: 0.00
BIOA cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 0.00
BIOA cash_flow (quarterly, 2024-12-31) — Net Short Term Debt Issuance: 0.00
BIOA balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 323127000.00
BIOA balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 4674000.00
BIOA balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 4674000.00
BIOA balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 4674000.00
BIOA balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Revenue: 4674000.00
BIOA income_statement (annual, 2024-12-31) — Normalized EBITDA: -68398000.00
BIOA income_statement (annual, 2024-12-31) — Normalized Income: -70932000.00
BIOA cash_flow (annual, 2024-12-31) — Operating Cash Flow: -51522000.00
BIOA cash_flow (annual, 2024-12-31) — Operating Gains Losses: 232000.00
BIOA income_statement (annual, 2024-12-31) — Operating Income: -78194000.00
BIOA income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
BIOA balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 35850037.00
BIOA balance_sheet (annual, 2024-12-31) — Other Current Assets: 2754000.00
BIOA balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 6000000.00
BIOA balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 417000.00
BIOA balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 245000.00
BIOA income_statement (annual, 2024-12-31) — Other Gand A: 19158000.00
BIOA income_statement (annual, 2024-12-31) — Other Income Expense: -177000.00
BIOA balance_sheet (annual, 2024-12-31) — Other Investments: 100000.00
BIOA cash_flow (annual, 2024-12-31) — Other Non Cash Items: 1033000.00
BIOA balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 240000.00
BIOA balance_sheet (annual, 2024-12-31) — Other Properties: 869000.00
BIOA balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 0.00
BIOA income_statement (annual, 2024-12-31) — Other Special Charges: 250000.00
BIOA income_statement (quarterly, 2024-12-31) — Other Special Charges: 0.00
BIOA balance_sheet (annual, 2024-12-31) — Payables: 1996000.00
BIOA balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 13330000.00
BIOA balance_sheet (annual, 2024-12-31) — Preferred Securities Outside Stock Equity: 0.00
BIOA balance_sheet (quarterly, 2024-12-31) — Preferred Securities Outside Stock Equity: 0.00
BIOA balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
BIOA cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 170000000.00
BIOA cash_flow (quarterly, 2024-12-31) — Preferred Stock Issuance: 0.00
BIOA income_statement (annual, 2024-12-31) — Pretax Income: -71109000.00
BIOA cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 634000.00
BIOA balance_sheet (annual, 2024-12-31) — Properties: 0.00
BIOA cash_flow (annual, 2024-12-31) — Purchase Of Investment: 0.00
BIOA cash_flow (annual, 2024-12-31) — Purchase Of PPE: -366000.00
BIOA balance_sheet (annual, 2024-12-31) — Receivables: 0.00
BIOA income_statement (annual, 2024-12-31) — Reconciled Depreciation: 167000.00
BIOA cash_flow (annual, 2024-12-31) — Repayment Of Debt: -6000000.00
BIOA income_statement (annual, 2024-12-31) — Research And Development: 59036000.00
BIOA balance_sheet (annual, 2024-12-31) — Restricted Cash: 0.00
BIOA balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 0.00
BIOA balance_sheet (annual, 2024-12-31) — Retained Earnings: -252811000.00
BIOA cash_flow (annual, 2024-12-31) — Sale Of Investment: 0.00
BIOA income_statement (annual, 2024-12-31) — Selling General And Administration: 19158000.00
BIOA balance_sheet (annual, 2024-12-31) — Share Issued: 35850037.00
BIOA cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 0.00
BIOA cash_flow (quarterly, 2024-12-31) — Short Term Debt Issuance: 0.00
BIOA income_statement (annual, 2024-12-31) — Special Income Charges: -250000.00
BIOA income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
BIOA cash_flow (annual, 2024-12-31) — Stock Based Compensation: 6979000.00
BIOA balance_sheet (annual, 2024-12-31) — Stockholders Equity: 323127000.00
BIOA balance_sheet (annual, 2024-12-31) — Tangible Book Value: 323127000.00
BIOA income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
BIOA income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
BIOA balance_sheet (annual, 2024-12-31) — Total Assets: 358234000.00
BIOA balance_sheet (annual, 2024-12-31) — Total Capitalization: 325629000.00
BIOA balance_sheet (annual, 2024-12-31) — Total Debt: 8704000.00
BIOA balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 323127000.00
BIOA income_statement (annual, 2024-12-31) — Total Expenses: 78194000.00
BIOA balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 35107000.00
BIOA balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 1131000.00
BIOA balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 7332000.00
BIOA income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -78194000.00
BIOA income_statement (annual, 2024-12-31) — Total Unusual Items: -177000.00
BIOA income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -177000.00
BIOA balance_sheet (annual, 2024-12-31) — Working Capital: 329328000.00
BIOA income_statement (quarterly, 2025-03-31) — +Operating Expense: 17897000.00
BIOA income_statement (quarterly, 2025-03-31) — +Total Revenue: 1451000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 3989000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 361000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -408000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 578642000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 14559000.00
BIOA income_statement (quarterly, 2025-03-31) — Basic Average Shares: 35850037.00
BIOA income_statement (quarterly, 2025-03-31) — Basic EPS: -0.36
BIOA cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 354349000.00
BIOA cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -426000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 3256000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Capital Stock: 0.00
BIOA balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 257486000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 320518000.00
BIOA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -1500000.00
BIOA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -77988000.00
BIOA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -17363000.00
BIOA cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 2047000.00
BIOA cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -6949000.00
BIOA cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 1000.00
BIOA cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -1090000.00
BIOA cash_flow (quarterly, 2025-03-31) — Change In Payable: 2047000.00
BIOA cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -4902000.00
BIOA cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -1180000.00
BIOA cash_flow (quarterly, 2025-03-31) — Change In Receivables: -361000.00
BIOA cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -7532000.00
BIOA cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -361000.00
BIOA cash_flow (quarterly, 2025-03-31) — Changes In Cash: -96851000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Common Stock: 0.00
BIOA balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 313167000.00
BIOA cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
BIOA balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 52000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 4308000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Current Assets: 324813000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 700000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Current Debt: 6000000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 6700000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 8183000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 8183000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 23738000.00
BIOA cash_flow (quarterly, 2025-03-31) — Depreciation: 37000.00
BIOA cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 37000.00
BIOA cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 37000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 97000.00
BIOA income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 35850037.00
BIOA income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.36
BIOA income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -12928000.00
BIOA income_statement (quarterly, 2025-03-31) — EBIT: -12673000.00
BIOA income_statement (quarterly, 2025-03-31) — EBITDA: -12636000.00
BIOA cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -12000.00
BIOA cash_flow (quarterly, 2025-03-31) — End Cash Position: 257486000.00
BIOA cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -1500000.00
BIOA cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -17789000.00
BIOA cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -59000.00
BIOA income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 59000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 264000.00
BIOA income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 6788000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Gross PPE: 4538000.00
BIOA income_statement (quarterly, 2025-03-31) — Interest Expense: 255000.00
BIOA income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 255000.00
BIOA income_statement (quarterly, 2025-03-31) — Interest Income: 3714000.00
BIOA income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 3714000.00
BIOA cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 217000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Invested Capital: 320223000.00
BIOA cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -77988000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 14559000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 14659000.00
BIOA cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
BIOA balance_sheet (quarterly, 2025-03-31) — Leases: 113000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 2556000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 1056000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 3612000.00
BIOA cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -1500000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 237000.00
BIOA cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
BIOA income_statement (quarterly, 2025-03-31) — Net Income: -12928000.00
BIOA income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -12928000.00
BIOA income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -12928000.00
BIOA income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -12928000.00
BIOA income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -12928000.00
BIOA cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -12928000.00
BIOA income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -12928000.00
BIOA income_statement (quarterly, 2025-03-31) — Net Interest Income: 3459000.00
BIOA cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -77562000.00
BIOA cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -1500000.00
BIOA cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -1500000.00
BIOA income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 3459000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Net PPE: 4130000.00
BIOA cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -426000.00
BIOA cash_flow (quarterly, 2025-03-31) — Net Preferred Stock Issuance: 0.00
BIOA balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 313167000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 3227000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 3227000.00
BIOA income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -12695000.00
BIOA income_statement (quarterly, 2025-03-31) — Normalized Income: -12987000.00
BIOA cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -17363000.00
BIOA cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -59000.00
BIOA income_statement (quarterly, 2025-03-31) — Operating Income: -16446000.00
BIOA income_statement (quarterly, 2025-03-31) — Operating Revenue: 1451000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 35850037.00
BIOA balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 3934000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 6000000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 558000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 264000.00
BIOA income_statement (quarterly, 2025-03-31) — Other Gand A: 6788000.00
BIOA income_statement (quarterly, 2025-03-31) — Other Income Expense: 59000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Other Investments: 100000.00
BIOA cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 170000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 239000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Other Properties: 4136000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 63032000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Payables: 3989000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 8297000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
BIOA cash_flow (quarterly, 2025-03-31) — Preferred Stock Issuance: 0.00
BIOA income_statement (quarterly, 2025-03-31) — Pretax Income: -12928000.00
BIOA cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
BIOA balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
BIOA cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -77562000.00
BIOA cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -426000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Receivables: 361000.00
BIOA income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 37000.00
BIOA cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -1500000.00
BIOA income_statement (quarterly, 2025-03-31) — Research And Development: 11109000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -265739000.00
BIOA cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 0.00
BIOA income_statement (quarterly, 2025-03-31) — Selling General And Administration: 6788000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Share Issued: 35850037.00
BIOA income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
BIOA cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 2949000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 313167000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 313167000.00
BIOA income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
BIOA income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
BIOA balance_sheet (quarterly, 2025-03-31) — Total Assets: 343841000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 314223000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Total Debt: 10312000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 313167000.00
BIOA income_statement (quarterly, 2025-03-31) — Total Expenses: 17897000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 30674000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 19028000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 6936000.00
BIOA income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -16446000.00
BIOA income_statement (quarterly, 2025-03-31) — Total Unusual Items: 59000.00
BIOA income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 59000.00
BIOA balance_sheet (quarterly, 2025-03-31) — Working Capital: 301075000.00
BIOA income_statement (quarterly, 2025-06-30) — +Operating Expense: 27183000.00
BIOA income_statement (quarterly, 2025-06-30) — +Total Revenue: 2412000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1329000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 603000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -462000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 581871000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 16108000.00
BIOA income_statement (quarterly, 2025-06-30) — Basic Average Shares: 35850037.00
BIOA income_statement (quarterly, 2025-06-30) — Basic EPS: -0.60
BIOA cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 257486000.00
BIOA cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -159000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 3150000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Capital Stock: 0.00
BIOA balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 220330000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 297295000.00
BIOA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -1500000.00
BIOA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -15641000.00
BIOA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -19969000.00
BIOA cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -2597000.00
BIOA cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 2725000.00
BIOA cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 2000.00
BIOA cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -1810000.00
BIOA cash_flow (quarterly, 2025-06-30) — Change In Payable: -2597000.00
BIOA cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 128000.00
BIOA cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 135000.00
BIOA cash_flow (quarterly, 2025-06-30) — Change In Receivables: -242000.00
BIOA cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -1787000.00
BIOA cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -242000.00
BIOA cash_flow (quarterly, 2025-06-30) — Changes In Cash: -37110000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Common Stock: 0.00
BIOA balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 294781000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 52000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 6673000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Current Assets: 301697000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 630000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Current Debt: 5596000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 6226000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 7698000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 7698000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 22837000.00
BIOA cash_flow (quarterly, 2025-06-30) — Depreciation: 58000.00
BIOA cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 58000.00
BIOA cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 58000.00
BIOA balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 108000.00
BIOA income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 35850037.00
BIOA income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.60